Abstract: An apparatus including a strake section having a plurality of helical fins separated by at least one helical opening. A method including forming a helically shaped fin that independently maintains the helical shape once formed.

Abstract: An apparatus including a fairing having a tail portion and an end portion capable of suppressing a vortex-induced vibration of a tubular. The apparatus further including a stabilizing member attached to the end portion of the fairing, the stabilizing member dimensioned to increase a thickness of the end portion of the fairing and a flange member attached to the stabilizing member, the flange member dimensioned to increase a chord dimension of the fairing so as to improve a stability of the fairing.

Abstract: A networked computer system passes messages between source devices and destination devices based on source selections made by users of the destination devices. The source selections are based on taking into content contributed by the users. Overlap and duplication of content can be reduced in a datastream to enhance a user experience.

Abstract: A networked computer system identifies, optimizes and recommends content sources for users. The content sources can be used for providing news feeds, search results, etc. based on taking into net useful content contributed by such sources over other sources.

Abstract: A needle magazine for holding a plurality of injection needles (50) is described. The needle magazine comprises a first opening adapted to receive the device fluid access portion (120) of a medical delivery device. Each needle (50) is selectively moveable from a respective storage position not aligned with said first opening into a needle mounting position aligned with said first opening. The needle magazine further comprises needle positioning means (41). configured to alter the mutual position between a needle selected from said plurality of needles (50) relative to a neighbour needle when said selected needle moves from its storage position to the needle mounting position.

Abstract: The various embodiments of the present inventions provide stabilization devices and methods for use of the stabilization devices with minimally invasive gynecological procedures such as methods of preventing pregnancy by inserting intrafallopian contraceptive devices into the fallopian tubes.

Abstract: A system and method for moving an object is disclosed. In one aspect, there is a device for moving an object. The device comprises a penetrating structure comprising an externally threaded surface. The device further comprises a receiving structure comprising an internally threaded cylinder surrounding the penetrating structure. The device further comprises a source of magnetic flux configured to magnetize the externally threaded surface with a first polarity and to magnetize the internally threaded cylinder with a second polarity that is different from the first polarity. The device further comprises a conductor positioned between the penetrating structure and the receiving structure configured to conduct an electric current. The device further comprises a sensor configured to determine the radial position of the penetrating structure with respect to the receiving structure.

Abstract: The various embodiments of the present inventions provide stabilization devices and methods for use of the stabilization devices with minimally invasive gynecological procedures such as methods of preventing pregnancy by inserting intrafallopian contraceptive devices into the fallopian tubes

Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to myostatin, and that function to inhibit myostatin. The invention also relates to human anti-myostatin antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-myostatin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-myostatin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-myostatin antibodies.

Abstract: The various embodiments of the present inventions provide stabilization devices and methods for use of the stabilization devices with minimally invasive gynecological procedures such as methods of preventing pregnancy by inserting intrafallopian contraceptive devices into the fallopian tubes.

Abstract: A method and system for transportation using a magnetic bearing structure is disclosed. In one aspect, an apparatus for carrying a load comprises a source of magnetic flux and a controller configured to control the position of the source of magnetic flux relative to a magnetizable structure. The source of magnetic flux comprises a first upper portion and a first lower portion of opposite polarities. The first portions are spaced apart horizontally from a first side of the magnetizable structure. The source of magnetic flux further comprises a second upper portion and a second lower portion of opposite polarities. The second portions are spaced apart horizontally from a second side of the magnetizable structure. The second side is opposite the first side. The first and second upper portions are magnetically attracted to an upper portion of the magnetizable structure and the first and second lower portions are magnetically attracted to a lower portion of the magnetizable structure.

Abstract: A container consisting of a PCTFE monolayer, the thickness of said layer being about 40-100 ?m, which container is equipped with a device where the liquid can be lead out through when desired and which container is transparent, shows superior properties for storing liquid pharmaceutical compositions, especially insulin compositions containing preservatives.

Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to myostatin, and that function to inhibit myostatin. The invention also relates to human anti-myostatin antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-myostatin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-myostatin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-myostatin antibodies.

Abstract: A system and an apparatus for use in detecting a target microorganism or agent is disclosed which involves a solid support carrying a binding partner specific for the particular microorganism or agent and the solid support being characterised in that it defines means for protecting the binding partner from being dislodged or scraped off the solid support by physical means. The provision of protection against the binding partner being dislodged from or scraped off the solid support improves the reliability of tests such as immunoassays being conducted with the solid support and also enables such tests to be automated. Modules and machines for use with the solid support, and the automated conduct of tests are also disclosed.

Abstract: The present invention is transgenic chickens obtained from long-term cultures of avian PGCs and techniques to produce and transgenic birds derived from prolonged PGC cultures. In some embodiments, these PGCs can be transfected with genetic constructs to modify the DNA of the PGC, specifically to introduce a transgene encoding an exogenous protein. When combined with a host avian embryo by known procedures, those modified PGCs are transmitted through the germline to yield transgenic offspring. This invention includes compositions comprising long-term cultures of PGCs and offspring derived from them that are genetically modified.

Abstract: This disclosure describes an electromagnetic system for efficient propulsion, suspension, and guidance. The track is inexpensive totally passive steel. This linear form of the D.C. motor provides traction motor characteristics without physical contact, The moveable element (vehicle) comprises both the integrated armature and field magnet flux source which induces magnetizing flux into pairs of rails each energizing a set of interdigitated poles of alternating polarity in the track against which its own armature conductors interact for thrust and braking. This source of magnetic flux requires no power and provides passive suspension at any speed and, with control, guidance. The permanent magnet and control flux in common airgaps multiply the effectiveness of lateral control for magnetic stabilization and to restrain external forces.

Abstract: A flexible multilayer film for forming a container defining a liquid-tight chamber for storing a liquid is described here. The film comprises a first layer (1) and a second layer (2). The first layer (1) is a barrier layer, for example, a PCTFE layer, which is arranged inwardly of the second layer (2) as seen in a direction from the chamber of the container formed from the multilayer film. The second layer (2) is a septum layer, for example, a TPE layer, having self-sealing properties so as to seal around a hypodermic needle penetrating said film. As seen in the above direction an innermost surface (5) of the film is weldable onto itself and is preferably made of a weldable layer (3) comprising PE and/or PP.

Abstract: A system and an apparatus for use in detecting a target microorganism or agent is disclosed which involves a solid support carrying a binding partner specific for the particular microorganism or agent and the solid support being characterised in that it defines means for protecting the binding partner from being dislodged or scraped off the solid support by physical means. The provision of protection against the binding partner being dislodged from or scraped off the solid support improves the reliability of tests such as immunoassays being conducted with the solid support and also enables such tests to be automated. Modules and machines for use with the solid support, and the automated conduct of tests are also disclosed.

Abstract: A system and an apparatus for use in detecting a target microorganism or agent is disclosed which involves a solid support carrying a binding partner specific for the particular microorganism or agent and the solid support being characterised in that it defines means for protecting the binding partner from being dislodged or scraped off the solid support by physical means. The provision of protection against the binding partner being dislodged from or scraped off the solid support improves the reliability of tests such as immunoassays being conducted with the solid support and also enables such tests to be automated. Modules and machines for use with the solid support, and the automated conduct of tests ate also disclosed.

Abstract: This invention is directed to compounds of the formula and the pharmaceutically-acceptable salts thereof, where the substituents are as defined in the Specification, which are growth hormone secretogogues and which increase the level of endogenous growth hormone. The compounds of this invention are useful for the treatment and prevention of osteoporosis and/or frailty, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair, attenuating protein catabolic response after a major operation, reducing cachexia and protein loss due to chronic illness, accelerating wound healing, or accelerating the recovery of burn patients or patients having undergone major surgery; improving muscle strength, mobility, maintenance of skin thickness, metabolic homeostasis or renal homeostasis.